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Introduction: Anorexia nervosa (AN) is a serious mental disorder that typically manifests
in adolescence. Motivation to change is an important predictor for treatment outcome in
adolescent AN, even though its development over the often long therapeutic process,
with transitions between treatment settings, has not yet been studied. In this pilot
study, the course of motivation to change and its effect on treatment outcome were
investigated over the course of a step-down treatment approach during a 12-month
observation period.
Methods: Twenty-one adolescents admitted to inpatient treatment because of AN
received multidisciplinary home treatment (HoT) with several weekly visits after short
inpatient stabilization. Eating disorder (ED-)specific cognitive [Eating Disorder Inventory
2 (EDI-2) subscales] and physical [% expected body weight (%EBW)] illness severity and
motivation to change [Anorexia Nervosa Stages of Change Questionnaire (ANSOCQ)]
were assessed at the time of admission, discharge from hospital, at the end of HoT,
and at a 12-month follow-up. Changes in motivation over time and its relationship with
treatment outcome were investigated.
Results: Mean motivation to change improved significantly over the course of treatment
from the contemplation stage [2nd stage, mean ANSOCQ sum score 47.26 (SD 17.60)]
at admission to the action stage [4th stage, mean ANSOCQ sum score 77.64 (SD 18.97)]
at the end of HoT (p < 0.001) and remained stable during the follow-up period. At
each assessment, higher motivation to change was significantly correlated with lower
ED-specific cognitive illness severity (Spearman ρs: −0.53 to −0.77, all p < 0.05).
Only pretreatment motivation to change significantly predicted ED-specific cognitive
illness severity after the first inpatient treatment phase when taking prior illness severity
into account.
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Conclusions: Motivation to change is an important aspect of treatment success
in adolescent AN, especially in the early phase of treatment. In addition, home
treatment contributed significantly to a higher motivation. Further longitudinal research
into how motivation to change in adolescent patients with AN is related to outcome
in this often severe and enduring disease and into targeted therapeutic strategies and
interventions that reliably enhance the motivation to change in adolescent patients with
AN seems promising.
Keywords: anorexia nervosa, adolescence, treatment setting, home treatment, motivation to change, ANSOCQ
INTRODUCTION
Anorexia nervosa (AN) is a serious mental disorder typically
manifesting itself in adolescence with high physical and mental
comorbidity (1), and, among all eating disorders (EDs), it has the
highest mortality (2). Additionally, at least one in five adolescent
patients develops severe and enduring ED (3). Therefore, early
and effective treatment is necessary to prevent protracted courses,
associated with high individual, familial and societal tolls (4).
Motivation to change is assumed to play a major role in
therapeutic engagement (5). Higher motivation to change at
admission is related to better treatment outcomes of AN [for
reviews see (6, 7)]. In a study by Hillen et al., adolescent patients
with a greater motivation to change at admission [investigated
with the Anorexia Nervosa Stages of Change Questionnaire
(ANSOCQ)] exhibited higher and more rapid weekly weight
gain during inpatient treatment until discharge (8). Furthermore,
an increase in motivation to change during the first two weeks
of inpatient treatment predicted improvements in ED-specific
psychopathology after 6 weeks of treatment in adolescents and
adults (9). Schlegl et al. identified therapist-rated motivation to
change at admission as a positive predictor of clinically significant
improvements in ED psychopathology at hospital discharge after
an average of 12 weeks in adult inpatients (10).
Motivation to change also seems to improve during treatment:
Hillen et al. investigated motivation to change at three time
points throughout inpatient treatment and found a significant
increase in motivation to change after an average of 15 weeks
of inpatient treatment (8). Castro-Fornieles et al. observed a
significant increase inmotivation to change across an average of 6
weeks of inpatient treatment in adolescent patients with AN (11).
Despite these findings of increased motivation during
inpatient treatment, children and adolescents perceive more
coercion (8) and often disagree more with hospitalization than
adult patients (12). However, there is little research onmotivation
to change in adolescent patients with AN in treatment settings
other than inpatient treatment. Pauli et al. found that higher
motivation to change at the beginning of mostly outpatient
Abbreviations: AN, anorexia nervosa; ANSOCQ, Anorexia Nervosa Stages of
Change Questionnaire; BMI, body mass index; ED, eating disorder; EDI-2, Eating
Disorder Inventory 2; HoT, home treatment; tAdm, time point of admission; tDisIP,
time point of discharge from inpatient treatment/time point of start of HoT;
tDisHoT, time point of discharge fromHoT; tFU, time point of follow-up, 12 months
after admission; %EBW, percentage of expected body weight.
treatment of adolescents predicted remission of AN after 9
months of treatment (13). Additionally, day-patient treatment
in adolescents (14) and in a mixed sample of adolescents and
young adults (15) was associated with a significant increase
in motivation to change (measured with the ANSOCQ) from
admission to discharge. In an uncontrolled case study of
adolescent patients with AN who were in day-patient treatment,
Simic and colleagues could show a significant increase in self-
perceived ability to recover across the treatment program (16).
These few but promising findings seem to suggest that treatment
settings other than inpatient treatment have a positive impact
on motivation to change in adolescent patients with AN, and
potentially even more effects.
However, most studies have investigated motivation to change
only after a relatively short time of intervention without a follow-
up assessment. There are two notable exceptions. First, the study
by Castro-Fornieles et al. found that higher motivation to change
at discharge from inpatient treatment was a predictor of target
weight maintenance 9 months later (11). However, motivation
to change was only investigated at admission and discharge, not
at follow-up. The second exception is the study by Goldstein
et al., who investigated motivation to change throughout a 10-
week day-patient treatment and found significant increases in
motivation at the 6-month follow-up (14). Nevertheless, these
studies are also limited in that they explore motivation to change
only during one treatment setting and not among patients across
different treatment settings. However, a change in treatment
setting is very common, especially in children and adolescents
with AN (17). Investigating motivation to change across
treatment settings in adolescent patients could lead to interesting
insights into the path to recovery to improve both treatments and
outcomes for these patients. A rather novel therapeutic concept
for adolescent patients with AN is home treatment (HoT). In
the current study, HoT was applied as a stepped care treatment
setting, comprising a first inpatient stabilization phase followed
by an intensive multidisciplinary home-visit program to shorten
hospitalizations (18).
In the current study, we aimed to address the aforementioned
gaps and to investigate the development of motivation to change
in a stepped care approach including the novel method of HoT
with a 12-month follow-up. In particular, we were interested in
whether our new home treatment method (HoT) would enhance
motivation to change. We hypothesized that, first, the motivation
to change would increase during inpatient treatment and HoT,
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second, that motivation to change would be related to ED illness
severity and, third, that motivation to change at the beginning
of each treatment setting would predict ED illness severity at the
end of each setting.
MATERIALS AND METHODS
Study Design and Treatment
The current study was part of a single-center, non-randomized,
open-label pilot study that was performed at a tertiary care
University clinic department for child and adolescent psychiatry
in Germany from May 2017 to December 2019. Our study was
approved by the local ethics committee and was undertaken
according to the Declaration of Helsinki and Good Clinical
Practice (GCP) regulations with independent data management.
Written informed consent was obtained from all patients and
their parents. The trial was registered in the German Clinical
Trials Register (DRKS00013075).
The actual treatment that was offered to adolescent patients
with AN can be divided into three phases: (A) an inpatient
somatic and mental stabilization phase, followed by (B) the
HoT itself, and (C) outpatient treatment as usual (mostly
psychotherapy and weight control once a week). The inpatient
treatment took place on a specialized ED treatment unit of the
department for child and adolescent psychiatry. The treatment
setting is multidisciplinary based on ED-specific cognitive-
behavioral principles including individual and ED-focused group
psychotherapy (psychoeducation, body image therapy, group
cognitive behavioral therapy, social skills), weight management
and rehabilitation, nutritional therapy with supervised meals and
parent training, occupational and art therapy, and physiotherapy.
Home treatment (HoT) takes the ED-specific treatment to the
individual home of the patient with multiple weekly visits by
a multidisciplinary team of medical doctors, psychotherapists,
nurses, and nutritional and occupational therapists over three
to four months (18). Therapeutic interventions are also based
on ED-specific cognitive behavioral principles. During the first
two months, each patient is visited three to four times per week,
over the third and 4th month one to two times per week, with
an additional weekly group therapy session and a mandatory
weekly family session [see also (18) for further details]. We
assessed the patients and the course of treatment at four time
points: a baseline assessment at hospital admission (tAdm), a
second assessment after inpatient stabilization before starting
HoT (tDisIP), and at discharge from HoT (tDisHoT). A fourth
follow-up assessment was scheduled 12 months after admission
(tFU). The patients’ target weight was generally set between
the 25th and the 30th age-adapted body mass index (BMI)
percentile. More detailed information on the sample, eligibility
criteria, assessments, and treatment effects has been reported
previously (18). In the current study, we aimed to investigate the
development of motivation to change across the treatment and
its effects on treatment outcome.
Participants
Participants were patients with AN or atypical AN according
to DSM-5 criteria admitted to the inpatient department due to
failure of outpatient treatment or somatic complications caused
by starvation. Patients aged between 12 and 18 years, without
severe somatic or mental comorbidities, and living with at least
one carer within a commute of 60min of the hospital were eligible
to participate. In the second inclusion step, before the beginning
of HoT, patients had to be able to eat autonomously (e.g., without
nasogastric tube), had exhibited sufficient weight gain (≥1.5 kg
in 4 weeks), and were still free of severe mental (e.g., suicidality)
or somatic comorbid disorders [for further details see (18)]. 21 of
the initially included 22 patients completed HoT and participated
in the follow-up assessment. Accordingly, only the data of the 21
patients were included in the current study. Demographic and
clinical parameters are displayed in Table 1 (see below).
Assessments
Motivation to Change
The Anorexia Nervosa Stages of Change Questionnaire
(ANSOCQ) is a 20-item self-report questionnaire that assesses
the patient’s readiness to recover from AN based on the
“motivational stages of change model” by Prochaska and
DiClemente (19, 20). Every item was answered on a Likert
scale ranging from 1 to 5, yielding a sum score between 20
and 100. If sum scores ranging from 20 to 30 are obtained,
patients are classified as being in the “Precontemplation” stage,
scores from 31 to 50 correspond to the “Contemplation” stage,
between 51 and 70 to the “Preparation” stage, between 71 and
90 to the “Action” stage, and scores between 91 and 100 define
the “Maintenance” stage. The first stage, “Precontemplation,”
represents the unawareness or unwillingness to change, while
the second stage, “Contemplation,” refers to recognizing the
benefits of change and thinking about change. The “Preparation”
stage means that patients intend to change soon and are working
on strategies, while the “Action” stage means that patients are
already actively working to change and that there is a measurable
behavior change. The final stage of change, “Maintenance”, is
TABLE 1 | Demographic data of the 21 participants.
Mean (SD) or n (%)
Age at admission (years) 15.10 (1.16)
Duration of illness (weeks) 50.67 (31.50)
Gender (female) 21 (100%)
AN restrictive subtype 21 (100%)
AN-type
Typical AN 18 (85.7%)
Atypical AN 3 (14.3%)
Current family situation
Living with both parents 19 (90.5%)
Living with one parent/patchwork family 2 (9.5%)
Number of inpatient treatments (including current)
1 18 (85.7%)
2 3 (14.3%)
SD, standard deviation; n, number; AN, anorexia nervosa.
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associated with relapse prevention (19). In our study, we used
the German version of the ANSOCQ (13).
ED-Specific Cognitive Illness Severity
The Eating Disorder Inventory 2 (EDI-2) is a self-report
questionnaire with 91 items mapping onto the following 11
psychological subscales: Body Dissatisfaction, Bulimia, Drive
for Thinness, Asceticism, Ineffectiveness, Social Insecurity,
Interpersonal Distrust, Perfectionism, Interoceptive Awareness,
Impulse Regulation, and Maturity Fears. The psychometric
properties of the German version of the EDI-2 have been
established by Paul and Thiel (21). The EDI-2 is a validated
instrument for AN with good psychometric properties (22). In
line with previous research (23–25), we only used the sum score
of the three ED-relevant subscales in the analyses: “Drive for
Thinness”, “Bulimia”, and “Body Dissatisfaction” as a measure
of cognitive ED illness severity. Internal reliability (Cronbach’s
alpha) of this ED-specific sum score was between 0.63 and 0.73
at the different time points.
ANSOCQ and EDI-2 were administered at baseline (tAdm),
the end of inpatient treatment (tDisIP), the end of home treatment
(tDisHoT), and 12 months postadmission (tFU).
ED-Specific Physical Illness Severity
The patient’s height and weight (in underwear) were measured
at every assessment to calculate the BMI and its age-specific
percentile and the percentage of expected body weight (% EBW)
[both based on the large German KIGGS study as reference
data (26)]. The later was used as the measure of physical ED
illness severity.
Statistics
Statistical analyses were conducted with IBM’s Statistical Package
for the Social Sciences (SPSS) version 25.0 (IBM Corp.,
Armonk, USA). The significance level was set to 5%, and
the results of the regressions are reported with predictors not
explaining any variance (p > 0.2) excluded. First, the data were
analyzed descriptively.
Change in Motivation Over Time
A repeated-measures ANOVA with Bonferroni-adjusted post hoc
analyses was performed to analyze the change in motivation
across the four time points from admission to the one-year
follow-up. Exploratively, a descriptive analysis was carried out to
detect the numbers of participants whose stage of motivation to
change improved, stayed unchanged, or declined between the end
of HoT and follow-up.
Association Between Motivation to Change and
Illness Severity at Each Assessment
To replicate the findings of earlier studies, Spearman correlations
were calculated to assess the relationship between motivation
to change (ANSOCQ) at admission and other variables at
tAdm, both measures of illness severity, age, and duration of
illness. In addition, the association of motivation to change
with both measures of illness severity (EDI-2, %EBW) at each
treatment setting change, i.e., at tDisIP, tDisHoT, and at tFU
(after regular outpatient treatment), were also assessed with
Spearman correlations.
Predictive Association of Motivation to Change for
Outcome Illness Severity
To identify whether motivation to change at each treatment stage
was associated with illness severity at the following assessment
across treatment, three stepwise regressions were performed with
cognitive or physical ED illness severity (EDI-2 subscales or
%EBW) as the dependent variable, and, in the first step, only
the ANSOCQ sum score of the previous assessment and, in
the second step, additionally, the ED illness severity (EDI-2
subscales and %EBW) of the previous assessment as well as age
as independent variables. For the final model, predictors with
p > 0.2 in the second step were removed.
RESULTS
All participants were female and had the restrictive subtype of
AN (see Table 1). Inpatient treatment lasted on average 7.5 (SD
1.0) weeks, home treatment 15.5 (SD 1.2) weeks, and outpatient
treatment as usual before follow-up 27.7 (SD 3.3) weeks. The
main results regarding improvements in ED psychopathology
and restoration of body weight during the treatment and follow-
up periods have been reported previously (18). The relevant
parameters for the current study are shown again for reference
in Table 2, together with the development of the motivation to
change (ANSOCQ) across assessments. The distribution of the
ANSOCQ stages at each assessment is displayed in Figure 1.
Change in Motivation Over Time
The patients’ motivation to change increased significantly during
treatment until the one-year follow-up [F(3, 60) = 38.58; p <
0.001] from a mean of 47.26 (SD 17.60) at tAdm, representing
the “Contemplation” stage (2nd stage of the model), to a mean
of 79.38 (SD 21.14) at tFU, representing the “Action” stage (see
Table 2). Bonferroni-adjusted post hoc analyses revealed pairwise
significant differences between most assessments [e.g., between
tAdm and tDisIP: −9.07, 95%–CI (−17.29 to −0.85); p = 0.025,
and between tDisIP and tDisHoT: −21.31, 95%–CI (−30.67 to
−11.95); p < 0.001], except for the period between tDisHoT
and tFU [−1.74, 95%–CI (−11.12 to 7.64); p = 1.00], when
the scores remained stable on average. The largest increase in
motivation between consecutive time points occurred during
the actual HoT treatment phase (with a mean increase of 21.31
points corresponding to one stage of change). At follow-up, most
patients (76.1%) had remained in the same stage of motivation to
change or had even increased their motivation: 9 patients (42.9%)
improved their stage by 1 until follow-up, 7 patients (33.3%)
reported the same stage of motivation to change at follow-up as
at the end of the HoT, and 5 patients (23.8%) declined by 1 (4;
19.0%) or 2 (1; 4.8%) stages (see Figure 2).
Association Between Motivation to Change
and Illness Severity at Each Assessment
At tAdm, each setting change, and at tFU, higher motivation
to change was always significantly correlated with less severe
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TABLE 2 | Development of patients’ motivation to change, cognitive ED illness severity (EDI-2), BMI and BMI-percentile, and physical illness severity (%EBW) at the
beginning of each treatment phase and at the one-year follow-up.
Indices of illness severity Admission (tAdm) Start of Home Treatment (tDisIP) End of Home Treatment (tDisHoT) 1-Year Follow-up (tFU)
n = 21
n (%) or mean (SD); Min; Max
ANSOCQ sum score 47.26 (17.60); 24.00; 81.50 56.33 (18.31); 24.00; 92.00 77.64 (18.97); 30.00; 99.00 79.38 (21.14); 29.00; 97.00
precontemplation 5 (23.8%) 1 (4.8%) 0 2 (9.5%)
contemplation 6 (28.6%) 8 (38.1%) 2 (9.5%) 1 (4.8%)
preparation 9 (42.9%) 6 (28.6%) 5 (23.8%) 0
action 1 (4.8%) 5 (23.8%) 8 (38.1%) 10 (47.6%)




79.29 (18.85); 31.00; 107.00 72.43 (20.44); 31.00; 107.00 66.43 (19.35); 29.00; 106.00 61.33 (22.39); 25.00; 104.00
BMI 16.32 (1.14); 14.74; 18.61 18.39 (1.02); 16.78; 20.29 19.66 (1.03); 17.57; 21.15 19.72 (1.32); 17.09; 21.91
BMI percentile 3.77 (4.40); 0.01; 14.31 17.63 (10.70); 2.38; 41.06 31.19 (10.17); 12.18; 44.77 28.96 (14.98); 3.87; 62.30
Physical illness severity
(%EBW)
78.27 (4.89); 68.98; 86.52 87.83 (4.45); 79.91; 96.70 93.28 (3.76); 86.71; 98.14 92.52 (5.72); 80.77; 105.15
N, number; SD, standard deviation; Min, minimum; Max, maximum; ANSOCQ, Anorexia Nervosa Stages of Change Questionnaire; ED, eating disorder; BMI, body mass index; %EBW,
percentage of expected body weight; EDI-2, eating disorder inventory 2.
FIGURE 1 | Overview of the distribution of the motivational stages at the different time points according to the ANSOCQ (Anorexia Nervosa Stages of Change
Questionnaire). tAdm, admission; tDisIP, discharge from inpatient treatment; tDisHOT, discharge from home treatment; tFU, follow-up.
cognitive ED illness severity, with consistently strong correlations
between −0.53 and −0.77 (see Table 3). The relationship
between the physical index of illness severity (%EBW) and
motivation to change was generally less pronounced (Spearman
ρs: −0.21 to −0.39) and was not significant in our rather
small sample. At admission, patients with higher relative body
weight tended to have lower motivation, while this trend was
reversed at the follow-up (see Table 2). The duration of illness
and the participants’ age were not significantly associated with
the ANSCOQ sum score at admission in this sample.
Predictive Association of Motivation to
Change for Outcome Illness Severity
If only motivation to change was taken into account, its level at
the beginning of each setting was significantly associated with
cognitive ED illness severity (ED-specific EDI-2 subscales) at
the next assessment in an inverse linear manner [see Table 4
(step 1 for all time points)]. Pre-treatment motivation to change
at tAdm explained 55.8% of the variance of the cognitive ED
illness severity at tDisIP. Together with cognitive ED illness
severity at hospital admission, it explained 68.9% of the variance
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FIGURE 2 | Change in motivational stages of the ANSOCQ of the individual patients between discharge from home treatment and follow-up. ANSOCQ, anorexia
nervosa stages of change questionnaire; tDisHOT, discharge from home treatment; tFU, follow-up.
TABLE 3 | Correlation of the ANSOCQ sum scores at all four measuring times with illness severity (ED-specific sum scores of EDI-2 and %EBW) and baseline
characteristics.
Variables and assessment time points tAdm tDisIP tDisHoT tFU
ANSOCQ /EDI-2 −0.611 (0.003) −0.770 (<0.001) −0.704 (<0.001) −0.528 (0.014)
/%EBW −0.353 (0.12) −0.216 (0.35) −0.214 (0.35) 0.385 (0.09)
/duration of illness [wks] 0.192 (0.40) — — —
/age at tAdm 0.053 (0.82) — — —
Spearman correlation coefficient (p-value); ANSOCQ, Anorexia Nervosa Stages of Change Questionnaire; ED, eating disorder; EDI-2, Eating Disorder Inventory 2; %EBW, percentage
of expected body weight; tAdm, admission; tDisIP, discharge from inpatient treatment; tDisHoT , discharge from home treatment; tFU, follow-up; wks, weeks.
of the short-term outcome of cognitive ED illness severity at
tDisIP. However, this was only the case in the first treatment
phase during inpatient treatment. In the later treatment stages,
motivation to change did not explain additional variance in
cognitive ED illness severity at the consecutive time point if
cognitive ED illness severity of the previous assessment was taken
into account as well. Neither age nor %EBW of the previous
assessment explained variance in cognitive ED illness severity
significantly. At none of the assessments did motivation to
change predict physical ED illness severity (%EBW) of the next
assessment time point.
DISCUSSION
In our prospective pilot study, motivation to change increased
significantly during all treatment phases of the step-down
approach of brief somatic inpatient stabilization followed by
the novel treatment of AN-specific HoT and remained stable
until follow-up. At each assessment stage, higher motivation
to change was significantly related to cognitive ED illness
severity in a negative inverse manner. Only in the first phase
of treatment did motivation to change prove to be a significant
additional predictor of cognitive ED illness severity at the end
of the inpatient treatment phase. To the best of our knowledge,
this is the first study to investigate motivation to change
comprehensively in different treatment settings over a 12-month
period. According to our results, the new method of home-based
treatment showed the largest increase in motivation to change,
which assures us that it is a valuable strategy to enhance the
compliance of adolescent patients with AN.
In our sample, motivation to change increased significantly
across treatment. This finding is in line with previous studies of
adolescent and adult patients with AN in inpatient, outpatient,
and day-patient treatments (9, 14–16, 27). Hillen et al. reported
a significant increase in motivation to change over an average
inpatient treatment period of 15.1 weeks (8). In Castro-Fornieles
et al.’s study, the patients reported a significantly improved
motivation to change after approximately 4 weeks of inpatient
treatment (11). Goldstein et al. reported significant increases
in motivation to change after approximately 10 weeks of day-
patient treatment and at a 6-month follow-up (14). Nonetheless,
our study extends the previous findings by showing consistent
significant increases across several treatment setting changes.
Between discharge from HoT and the follow-up, three in four
patients remained in their stage of motivation to change or
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TABLE 4 | Results of the stepwise regressions of the motivation to change
(ANSOCQ sum scores) with cognitive ED illness severity (ED-specific sum score of
the EDI-2) over consecutive assessments.
Predictors and assessment
time point
R2-change B SE P
Inpatient treatment. Association between motivation to change and
cognitive ED illness severity.
Step 1 0.56 <0.001
Motivation tAdm −0.87 0.18 <0.001
Step 2 0.14 0.109
Motivation tAdm −0.51 0.22 0.036
Cognitive ED illness severity tAdm 0.49 0.21 0.035
%EBW tAdm 0.26 0.61 0.910
age 0.76 2.63 0.852
Step 31 0.69 0.018
Motivation tAdm −0.52 0.20 0.018
Cognitive ED illness severity tAdm 0.51 0.19 0.013
Total R2 (adj.) 0.66
Home treatment. Association between motivation to change and
cognitive ED illness severity.
Step 1 0.41 0.002
Motivation tDisIP −0.67 0.19 0.002
Step 2 0.27 0.020
Motivation tDisIP −0.12 0.25 0.627
Cognitive ED illness severity tDisIP 0.60 0.24 0.021
%EBW tDisIP 0.63 0.66 0.357
age 3.23 2.48 0.211
Step 3a 0.63 <0.001
Cognitive ED illness severity tDisIP 0.75 0.13 <0.001
Total R2 (adj.) 0.61
Outpatient treatment. Association between motivation to change and
cognitive ED illness severity.
Step 1 0.21 0.036
Motivation tDisHoT −0.54 0.24 0.036
Step 2 0.14 0.377
Motivation tDisHoT −0.25 0.33 0.430
Cognitive ED illness severity
tDisHoT
0.47 0.39 0.077
%EBW tDisHoT 0.51 1.53 0.742
age −0.88 4.22 0.837
Step 3a 0.32 0.008
Cognitive ED illness severity
tDisHoT
0.65 0.22 0.008
Total R2 (adj.) 0.28
ANSOCQ, Anorexia Nervosa Stages of Change Questionnaire; ED, eating disorder; EDI-
2, Eating Disorder Inventory 2; tAdm, admission; %EBW, percentage of expected body
weight; tDisIP, discharge from inpatient treatment; tDisHoT , discharge from home treatment;
afinal model, predictors with p > 0.2 (motivation in the 2nd step) were removed.
improved, while only one in four patients declined in their
stage. Our sample size did not allow further subsample analyses,
but, if replicated, future studies with larger samples could
investigate a possible clinical implication of change in motivation
after discharge.
A finding that has not yet been previously reported is the
great increase inmotivation to change in our patient sample from
hospital admission to the start of HoT and further until the end
of HoT by an average of 30 points, corresponding to ∼1.5 stages
of change. The mean score at admission of our sample was even
slightly lower than those in other studies (8, 11, 14). The mean
ANSOCQ sum scores at discharge (77.64) and follow-up (79.38)
in our study were higher than the scores of all other studies,
which reported mean values. Only in the studies of Hillen et al.
(at discharge) and Goldstein et al. (at the 6-month follow-up) did
adolescent patients with AN achieve mean values higher than 70
points, indicating the “Action” stage of change (8, 14). This may
emphasize that motivation to change increased especially during
our new treatment program: home-based treatment might
motivate the patients more than treatment as usual because it
facilitates the return home and helps to maintain the adolescents’
social lives. It has been shown previously that friendships and
peer support are positively associated with motivation to change
in patients with AN (28), which might underlie this HoT-specific
increase. Also, the patients and families actively opted for HoT as
their treatment setting of choice; active involvement in treatment
organization probably enhances motivation to change in patients
with AN (5). In addition, motivation to change might have
changed because of the long-term psychotherapeutic treatment
at home of approximately 22 weeks.
Higher motivation to change at admission was associated with
less severe ED-specific symptoms at admission. This finding is
in line with prior studies (8, 13): Pauli et al. found significant
negative correlations between the ANSOCQ and the EDI-2
“Drive for Thinness” scale at admission to outpatient treatment in
adolescents with AN (13). In addition to similar findings between
motivation and ED illness severity at admission, Hillen et al. also
reported significant associations of higher motivation to change
with lower %EBW at admission and longer duration of illness (8).
Patients with a longer duration of illness and severe underweight
might have experienced more somatic and psychological strain
before admission, leading to higher motivation to change in
comparison with patients with better somatic health. In our
sample, at admission, lower %EBW in the patients also tended
to be associated with higher motivation in the patients, but
the relationship was not significant in our rather small sample.
There was also no association between duration of illness and
motivation to change.
The difference in sample size might partially explain the
difference in these findings. Moreover, the duration of illness
had a larger range (3–40 months) in Hillen et al.’s cohort than
in our sample (1–27 months). Interestingly, the trend of the
association of lower %EBW with higher motivation at admission
was reversed in our sample at follow-up, with higher motivation
being at trend-level significance associated with higher %EBW,
suggesting an association between higher motivation to change
at follow-up and better maintenance of %EBW.
Similar to previous findings, higher motivation to change at
admission was predictive lower cognitive ED illness severity after
inpatient treatment, cognitive ED illness severity at admission
into account [e.g., (9)]. During the later stages of our step-down
treatment approach, the relationship between motivation to
change at the beginning cognitive ED illness severity at the end
of each treatment phase, adjusted for prior cognitive ED illness
Frontiers in Psychiatry | www.frontiersin.org 7 October 2021 | Volume 12 | Article 693103
Heider et al. Motivation in Adolescents With AN
severity, was not significant. This corresponds to a result by
Ackard et al., who did not find that stage of change predicted
ED-specific illness severity at 3-, 6-, and 12 months follow-up
although they used a different instrument than the ANSOCQ
(29). A potential explanation might be that high motivation
to change facilitates early improvement independent of illness
severity, while for long-term recovery, individual illness severity
might be a more relevant predictor. However, considering the
observational nature of our study and the strong correlations
between motivation to change and cognitive ED-specific illness
severity at each assessment, it is not completely clear which
factors were primarily responsible for the improvement in illness
severity during the later treatment phases.
Motivation to change of the previous assessment did not
predict weight as measured by %EBW at any stage of the
treatment process in our study, which contrasts with other
studies which reported an association [e.g., (11)]. This difference
might be explained by large differences in initial weights at
admission because of the inclusion of patients with atypical AN.
Moreover, a steady weight gain during inpatient treatment was
required to be transferred to HoT, and all patients had agreed to
achieve their target weight during HoT.
Some limitations must be considered when interpreting the
results. As mentioned already, our sample size of 21 participants
was small because it was a pilot and observational study to
investigate the effects of a new treatment method. To confirm our
results, especially whether HoT contributes more to motivation
to change in comparison with other intensive treatment settings,
randomized controlled trials seem to be necessary. In addition,
although the ANSOCQ is a validated and suitable measure to
assess motivation to change in the context of AN (27), other
assessment instruments were used in previous studies, which
might hinder the comparability of studies.
The results of our pilot study suggest several interesting
questions for future studies. Considering the large body of
evidence for an association between motivation to change
and treatment outcome in patients with AN, we suggest that
motivation to change should be investigated in longer-term
follow-up studies because of its potential to detect a risk of
relapse and enable timely intervention (30). Additionally, it
might be helpful to investigate the efficacy of (novel) treatment
concepts or settings for patients with AN regarding their ability to
improve the motivation to change, especially in the early phases
of treatment.
To conclude, motivation to change in an adolescent patient
sample with AN increased significantly during a step-down
treatment approach with changes in treatment settings, including
short inpatient treatment and a novel intensive HoT program.
Our results suggest that after discharge from this intensive
treatment program (HoT), the motivation to change remained
stable and was associated with reduced cognitive ED illness
severity. Further research into targeted therapeutic strategies and
interventions that reliably enhance the motivation to change in
patients with AN seems promising to improve the outcome of
this often severe, enduring, and disabling disease.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation.
ETHICS STATEMENT
The studies involving human participants were reviewed
and approved by Ethics Committee of the medical faculty,
RWTHUniversity Hospital Aachen, Germany.Written informed
consent to participate in this study was provided by the
participants’ legal guardian/next of kin.
AUTHOR CONTRIBUTIONS
BH-D, AD, and BD designed the study. SA and BD enrolled
patients into the study and contributed to data collection. KH
assisted with data collection. KH did the statistical analysis and
AD and BD supervised it. BD, BH-D, AD, and KH interpreted
the data. KH wrote the original draft of the paper and BD revised
it. BH-D, AD, SA, KH, and BD critically reviewed and corrected
the paper. All authors contributed to the article and approved the
submitted version.
FUNDING
Funding was provided by the Ministry of Labor, Health, and
Social Policies of the State of North-Rhine-Westphalia, Germany.
The funding source had no role in the design of the study,
its execution, data analyses, and interpretation, or decision to
submit results.
ACKNOWLEDGMENTS
We would like to thank the patients and their families for their
participation in the study.
REFERENCES
1. Herpertz-Dahlmann B. Adolescent eating disorders: update on definitions,
symptomatology, epidemiology, and comorbidity. Child Adolesc Psychiatr
Clin N Am. (2015) 24:177–96. doi: 10.1016/j.chc.2014.08.003
2. Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in
patients with anorexia nervosa and other eating disorders.
A meta-analysis of 36 studies. Arch Gen Psychiatry. (2011)
68:724–31. doi: 10.1001/archgenpsychiatry.2011.74
3. Dobrescu SR, Dinkler L, Gillberg C, Rastam M, Gillberg C, Wentz
E. Anorexia nervosa: 30-year outcome. Br J Psychiatry. (2020) 216:97–
104. doi: 10.1192/bjp.2019.113
4. Treasure J, Zipfel S, Micali N, Wade T, Stice E, Claudino A, et al.
Anorexia nervosa. Nat Rev Dis Primers. (2015) 1:15074. doi: 10.1038/nrdp.
2015.74
5. Darcy AM, Katz S, Fitzpatrick KK, Forsberg S, Utzinger L, Lock J. All
better? How former anorexia nervosa patients define recovery and engaged
in treatment. Eur Eat Disor Rev. (2010) 18:260–70. doi: 10.1002/erv.1020
6. Dray J, Wade TD. Is the transtheoretical model and motivational interviewing
approach applicable to the treatment of eating disorders? A review. Clin
Psychol Rev. (2012) 32:558–65. doi: 10.1016/j.cpr.2012.06.005
7. Clausen L, Lubeck M, Jones A. Motivation to change in the eating
disorders: a systematic review. Int J Eating Disord. (2013) 46:755–
63. doi: 10.1002/eat.22156
Frontiers in Psychiatry | www.frontiersin.org 8 October 2021 | Volume 12 | Article 693103
Heider et al. Motivation in Adolescents With AN
8. Hillen S, Dempfle A, Seitz J, Herpertz-Dahlmann B, Buhren K. Motivation
to change and perceptions of the admission process with respect
to outcome in adolescent anorexia nervosa. BMC Psychiatry. (2015)
15:140. doi: 10.1186/s12888-015-0516-8
9. Wade TD, Frayne A, Edwards SA, Robertson T, Gilchrist P.
Motivational change in an inpatient anorexia nervosa population
and implications for treatment. Aust N Z J Psych. (2009)
43:235–43. doi: 10.1080/00048670802653356
10. Schlegl S, Quadflieg N, Lowe B, Cuntz U, Voderholzer U. Specialized inpatient
treatment of adult anorexia nervosa: effectiveness and clinical significance of
changes. BMC Psychiatry. (2014) 14:258. doi: 10.1186/s12888-014-0258-z
11. Castro-Fornieles J, Casula V, Saura B, Martinez E, Lazaro L, Vila
M, et al. Predictors of weight maintenance after hospital discharge
in adolescent anorexia nervosa. Int J Eating Disord. (2007) 40:129–
35. doi: 10.1002/eat.20340
12. Angela S, Guarda MD, Angela Marinilli Pinto PD, Janelle W, Coughlin PD,
Shahana Hussain MRCP, et al. Perceived coercion and change in perceived
need for admission in patients hospitalized for eating disorders. Am J
Psychiatry. (2007) 164:108–14. doi: 10.1176/ajp.2007.164.1.108
13. Pauli D, Aebi M, Metzke CW, Steinhausen HC. Motivation to change, coping,
and selfesteem in adolescent anorexia nervosa: a validation study of the
anorexia nervosa stages of change questionnaire (ANSOCQ). J Eat Disord.
(2017) 5:11. doi: 10.1186/s40337-016-0125-z
14. Goldstein M, Peters L, Baillie A, McVeagh P, Minshall G, Fitzjames D. The
effectiveness of a day program for the treatment of adolescent anorexia
nervosa. Int J Eating Disord. (2011) 44:29–38. doi: 10.1002/eat.20789
15. Green J, Melvin GA, Newman L, Jones M, Taffe J, Gordon M. Day program
for young people with anorexia nervosa. Austr Psychiatry. (2015) 23:249–
53. doi: 10.1177/1039856215584513
16. Simic M, Stewart CS, Eisler I, Baudinet J, Hunt K, O’Brien J, et al. Intensive
treatment program (ITP): a case series service evaluation of the effectiveness
of day patient treatment for adolescents with a restrictive eating disorder. Int
J Eating Disord. (2018) 51:1261–9. doi: 10.1002/eat.22959
17. Herpertz-Dahlmann B, Bonin E, Dahmen B. Can you find the right support
for children, adolescents and young adults with anorexia nervosa: access to
age-appropriate care systems in various healthcare systems. Eur Eat Disorders
Rev. (2021) 29:316–28. doi: 10.1002/erv.2825
18. Herpertz-Dahlmann B, Borzikowsky C, Altdorf S, Heider K, Dempfle A,
Dahmen B. ‘Therapists in action’—home treatment in adolescent anorexia
nervosa: a stepped care approach to shorten inpatient treatment. Eur Eat
Disorders Rev. (2021) 29:427–42. doi: 10.1002/erv.2755
19. Prochaska JO, DiClemente CC. Stages of change in the modification of
problem behaviors. Prog Behav Modif. (1992) 28:183–218.
20. Rieger E, Touyz S, Schotte D, Beumont P, Russell J, Clarke
S, et al. Development of an instrument to assess readiness to
recover in anorexia nervosa. Int J Eat Disord. (2000) 28:387–
96. doi: 10.1002/1098-108X(200012)28:4<387::AID-EAT6>3.0.CO;2-Y
21. Paul T, Thiel A. Eating Disorder Inventory - 2: EDI-2; German Version;
Manual. Göttingen: Hogrefe (2005).
22. Micali N, House J. Assessment measures for child and adolescent
eating disorders: A review. Child Adolesc Ment Health. (2011) 16:122–
7. doi: 10.1111/j.1475-3588.2010.00579.x
23. Davis C, Claridge G, Cerullo D. Personality factors and weight
preoccupation: a continuum approach to the association between
eating disorders and personality disorders. J Psychiatr Res. (1997)
31:467–80. doi: 10.1016/S0022-3956(97)00006-X
24. DeSocio JE, O’Toole JK, He H, Crosby R, Koeller P, Baird SA, et al. Rating
of eating disorder severity interview for children: psychometric properties
and comparison with EDI-2 symptom index. Eur Eat Disord Rev. (2012)
20:70–7. doi: 10.1002/erv.1115
25. Pollock-BarZiv SM, Davis C. Personality factors and disordered eating in
young women with type 1 diabetes mellitus. Psychosomatics. (2005) 46:11–
8. doi: 10.1176/appi.psy.46.1.11
26. Schaffrath Rosario A, Kurth BM, Stolzenberg H, Ellert U, Neuhauser H. Body
mass index percentiles for children and adolescents in Germany based on a
nationally representative sample (KiGGS 2003–2006). Eur J Clin Nutr. (2010)
64:341–9 doi: 10.1038/ejcn.2010.8
27. Green J, Philipou A, Castle D, Cistullo L, Newton R. An evaluation of the
predictive validity of the URICA andANSOCQ scales for weight gain in adults
with AN in an outpatient eating disorders program: a prospective cohort
study. J Eat Disord. (2017) 5:50. doi: 10.1186/s40337-017-0180-0
28. Malmendier-Muehlschlegel A, Rosewall JK, Smith JG, Hugo P, Lask B.
Quality of friendships and motivation to change in adolescents with Anorexia
Nervosa. Eat Behav. (2016) 22:170–4. doi: 10.1016/j.eatbeh.2016.06.010
29. Ackard DM, Cronemeyer CL, Richter S, Egan A. Do symptom-specific stages
of change predict eating disorder treatment outcome? Eat Weight Disord Stud
Anore Bulimia Obesity. (2015) 20:49–62. doi: 10.1007/s40519-014-0153-0
30. Carter JC, Mercer-Lynn KB, Norwood SJ, Bewell-Weiss CV, Crosby
RD, Woodside DB, et al. A prospective study of predictors of
relapse in anorexia nervosa: implications for relapse prevention.
Psychiatry Res. (2012) 200:518–23. doi: 10.1016/j.psychres.2012.
04.037
Conflict of Interest: BH-D received a speaker’s fee from Ferring for a disease state
presentation.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2021 Heider, Dempfle, Altdorf, Herpertz-Dahlmann and Dahmen.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Psychiatry | www.frontiersin.org 9 October 2021 | Volume 12 | Article 693103
